The midpoint period between your suggested dates the insufflation study was possibly submitted to get a PDUFA date would be April 16, 2023. If PDUFA date was established at that time, it is possible that the company will receive approval of its OxyContin ANDA as early as February 16, 2023 if the usual 10 month waiting period applies.
Would you agree that this would be the biggest and most meaningful event in the history of the company? Do you think that it it happened, investors could buy this stock at or near the current price? Will your your mantra that no Nasdaq no increase in PPS apply?
News 
Market Data 
Discover 
AI
